| scholarly article | Q13442814 |
| P50 | author | Zhao Cui | Q96177313 |
| P2093 | author name string | Gang Liu | |
| Jing Huang | |||
| Ming-Hui Zhao | |||
| Xin Wang | |||
| Fang Wang | |||
| Zhen Qu | |||
| Li-Qiang Meng | |||
| Yi-Miao Zhang | |||
| Qiu-Hua Gu | |||
| P2860 | cites work | Differential modulation by glucocorticoids of alternative complement protein secretion in cells of the monocyte/macrophage lineage | Q68053989 |
| Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis | Q68216638 | ||
| Focal and segmental glomerulosclerosis. Immunohistologic study of 20 renal biopsy specimens | Q68975897 | ||
| Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis | Q70989780 | ||
| Disappearance of uremia due to heroin-associated nephropathy | Q72230790 | ||
| Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice | Q80209369 | ||
| The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy | Q80375869 | ||
| Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis | Q86215247 | ||
| Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy | Q30702085 | ||
| Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis | Q33872298 | ||
| Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. | Q34103749 | ||
| The double life of a B-1 cell: self-reactivity selects for protective effector functions | Q34154602 | ||
| A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis | Q34416768 | ||
| Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis | Q34660324 | ||
| CD2-associated protein and glomerular disease | Q35595375 | ||
| Complement Activation in Patients with Focal Segmental Glomerulosclerosis | Q35763276 | ||
| IgM exacerbates glomerular disease progression in complement-induced glomerulopathy | Q36016859 | ||
| B cell immunobiology in disease: evolving concepts from the clinic | Q36427357 | ||
| IgM contributes to glomerular injury in FSGS | Q36638347 | ||
| The spectrum of focal segmental glomerulosclerosis: new insights | Q37137417 | ||
| Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis | Q37297636 | ||
| Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome | Q37670299 | ||
| Focal segmental glomerulosclerosis | Q37970393 | ||
| Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy | Q38461198 | ||
| Nehprotic syndrome with glomerular mesangial IgM deposits | Q40881538 | ||
| Circulating heavy IgM in IgM nephropathy | Q41391912 | ||
| Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. | Q43617519 | ||
| Effect of cortisone therapy on serum complement components | Q47976055 | ||
| Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. | Q51933016 | ||
| The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. | Q53863570 | ||
| Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases. | Q54475370 | ||
| Pathologic classification of focal segmental glomerulosclerosis: a working proposal | Q56008651 | ||
| Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis | Q57624024 | ||
| Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood | Q57980385 | ||
| P433 | issue | 9 | |
| P921 | main subject | focal segmental glomerulosclerosis | Q1435223 |
| P304 | page(s) | 1582-1589 | |
| P577 | publication date | 2016-06-23 | |
| P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
| P1476 | title | Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis | |
| P478 | volume | 11 |
| Q57183273 | Clinical significance of mesangial IgM deposition in patients with IgA nephropathy |
| Q42086661 | Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea |
| Q92327732 | Complement and Complement Targeting Therapies in Glomerular Diseases |
| Q48133485 | Identification of sequence polymorphisms in the mitochondrial cytochrome c oxidase genes as risk factors for hepatocellular carcinoma. |
| Q38600476 | IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis |
| Q55555541 | Renal Tubular Complement 3 Deposition in Children with Primary Nephrotic Syndrome. |
| Q33826145 | Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis |
Search more.